Congress Learns About Treatment Options
On May 4, APA's Science Policy Office sponsored a congressional briefing entitled, "NIH Research in Action: Innovative Behavioral Treatments for Mental and Substance Use Disorders". To educate congressional staff about innovative treatments that have been developed with funding by the National Institutes of Health (NIH), APA brought in psychologists David H. Barlow, PhD, Professor of Psychology and Psychiatry, and Director, Boston University Center for Anxiety and Related Disorders, William R. Miller, PhD, Distinguished Professor of Psychology & Psychiatry, University of New Mexico, and Kathleen M. Carroll, PhD, Professor of Psychiatry, Yale University School of Medicine.
Dr. Barlow, whose research was funded by the National Institute of Mental Health, discussed the successful use of cognitive behavioral therapy in treating individuals with anxiety and panic disorders. Dr. Miller highlighted his own research that has been supported by the National Institute of Alcoholism and Alcohol Abuse and demonstrated the success of motivational interviewing, which nearly doubled the effectiveness of treatment for alcohol abuse..
Congressman Patrick Kennedy (D-RI) emphasizes the importance of substance abuse treatment research and expresses his continued support for increased FY06 funding for NIH.
Dr. Carroll highlighted the success of contingency management in successfully treating substance use research, which was shown to be effective even for involuntary patients. Dr. Carroll's research is supported by the National Institute on Drug Abuse.
Congressman Patrick Kennedy (D-RI) attended the briefing and also spoke briefly about the importance of both supporting research at the NIH, but also encouraging the adoption of these successful interventions into practice and requiring health insurance to cover treatments for all mental and emotional disorders.